UPDATE

UPDATES from DIA 2012: "Collaborate to innovate," says the association

By Natalie Morrison

- Last updated on GMT

UPDATES from DIA 2012: collaborative drug development
“Collaborate to innovate,” is the message DIA has for clinical researchers at its 2012 Annual Meeting in Philadelphia, US.

On Monday organisation opened the doors to its conference, and already Twitter has been flooded with news and views about drug development and how the DIA (Drug Information Association) is involved.

As always, the need for more innovation is a crucial issue, and better trial management systems is also a subject close to many’s hearts, with ethics in emerging markets, IRBs (institutional review boards), and paediatrics as some of the big topics.

Outsourcing-Pharma.com presents the cream of the crop as the show goes on…

Related news

Show more

Related products

show more

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers